OSAKA, Japan, Dec. 9, 2016 /PRNewswire/ — Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka; President & Representative Director, CEO: Dr. Masayuki Mitsuka) has presented data that show patients with amyotrophic lateral sclerosis (ALS) given …
( read original story …)